<DOC>
	<DOCNO>NCT01056978</DOCNO>
	<brief_summary>Even patient palliative care unit present well-recognized risk factor venous thromboembolism ( VTE ) ( eg : active cancer , bed rest , previous history venous thrombosis ) , incidence VTE palliative set unknown . By consequence , efficacy safety antithrombotic prophylaxis population establish . Indeed , patient admit palliative care unit include trial evaluate potential effect antithrombotic drug regard poor prognosis short term . In addition , main role prophylaxis prevent sudden death pulmonary embolus thus life prolong therapy view counterintuitive palliative care philosophy inappropriate ground futility . Nevertheless , current use Low Molecular Weight Heparin palliative care unit seem increase particularly patient advance malignancy . The identification high hemorrhagic risk palliative care patient could help decision antithrombotic prophylaxis initiation . For , investigator conduct multicenter prospective longitudinal study .</brief_summary>
	<brief_title>Predictive Factors Major Bleeding Risk Patients Admitted Palliative Care Unit</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>18 year admit palliative care unit cancer , pulmonary , cardiac neurologic advance disease life prognosis le 48 hour patient treat curative dos antithrombotic therapy patient follow 3 month possible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>palliative care unit</keyword>
	<keyword>bleeding</keyword>
	<keyword>thromboembolic</keyword>
	<keyword>hemorrhagic risk</keyword>
	<keyword>antithrombotic prophylaxis</keyword>
</DOC>